| 0 |
PHLEBITIS DEEP |
1 |
0.0135 |
| 1 |
PRIMARY IMMUNODEFICIENCY SYNDROME |
1 |
0.0123 |
| 2 |
STOMA SITE ABSCESS |
1 |
0.0041 |
| 3 |
ADMINISTRATION SITE ERYTHEMA |
1 |
0.0035 |
| 4 |
DEVICE COLOUR ISSUE |
1 |
0.0025 |
| 5 |
MECHANICAL URTICARIA |
1 |
0.0021 |
| 6 |
AUTOSCOPY |
1 |
0.0019 |
| 7 |
APPLICATION SITE INFLAMMATION |
1 |
0.0007 |
| 8 |
COSTOCHONDRITIS |
1 |
0.0006 |
| 9 |
STOMA SITE ERYTHEMA |
1 |
0.0005 |
| 10 |
BONE MARROW TRANSPLANT |
1 |
0.0005 |
| 11 |
DEVICE MATERIAL ISSUE |
1 |
0.0005 |
| 12 |
EYELID DISORDER |
1 |
0.0004 |
| 13 |
STOMA SITE DISCHARGE |
1 |
0.0004 |
| 14 |
THORACIC VERTEBRAL FRACTURE |
1 |
0.0003 |
| 15 |
THROMBOPHLEBITIS SUPERFICIAL |
1 |
0.0003 |
| 16 |
APPLICATION SITE DRYNESS |
1 |
0.0003 |
| 17 |
SNORING |
1 |
0.0003 |
| 18 |
PANIC DISORDER |
1 |
0.0003 |
| 19 |
EPIGASTRIC DISCOMFORT |
1 |
0.0003 |
| 20 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0002 |
| 21 |
APPLICATION SITE EXFOLIATION |
1 |
0.0002 |
| 22 |
EAR DISORDER |
1 |
0.0002 |
| 23 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 24 |
FLUID INTAKE REDUCED |
1 |
0.0002 |
| 25 |
APPLICATION SITE ERYTHEMA |
5 |
0.0002 |
| 26 |
HYDROCEPHALUS |
1 |
0.0002 |
| 27 |
APPLICATION SITE PAIN |
4 |
0.0002 |
| 28 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 29 |
APPLICATION SITE IRRITATION |
2 |
0.0002 |
| 30 |
TENDON DISORDER |
1 |
0.0002 |
| 31 |
ECCHYMOSIS |
1 |
0.0001 |
| 32 |
RASH PUSTULAR |
1 |
0.0001 |
| 33 |
FURUNCLE |
1 |
0.0001 |
| 34 |
BLOOD DISORDER |
1 |
0.0001 |
| 35 |
DECUBITUS ULCER |
1 |
0.0001 |
| 36 |
FLANK PAIN |
1 |
0.0001 |
| 37 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 38 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 39 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 40 |
ANKYLOSING SPONDYLITIS |
1 |
0.0001 |
| 41 |
DYSMENORRHOEA |
1 |
0.0001 |
| 42 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 43 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 44 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 45 |
SKIN DISCOLOURATION |
3 |
0.0001 |
| 46 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 47 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 48 |
COMPLICATION OF DEVICE REMOVAL |
1 |
0.0001 |
| 49 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 50 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 51 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 52 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 53 |
DRUG EFFECT DECREASED |
2 |
0.0000 |
| 54 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 55 |
HAEMATOCHEZIA |
2 |
0.0000 |
| 56 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 57 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 58 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 59 |
CYSTITIS |
1 |
0.0000 |
| 60 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 61 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 62 |
ANGER |
1 |
0.0000 |
| 63 |
HYPOXIA |
1 |
0.0000 |
| 64 |
ACNE |
2 |
0.0000 |
| 65 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 66 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 67 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 68 |
THERAPY CESSATION |
1 |
0.0000 |
| 69 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 70 |
RASH PRURITIC |
1 |
0.0000 |
| 71 |
OEDEMA |
1 |
0.0000 |
| 72 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 73 |
URTICARIA |
3 |
0.0000 |
| 74 |
BLISTER |
1 |
0.0000 |
| 75 |
BONE PAIN |
1 |
0.0000 |
| 76 |
CHILLS |
2 |
0.0000 |
| 77 |
NASAL CONGESTION |
1 |
0.0000 |
| 78 |
IRRITABILITY |
1 |
0.0000 |
| 79 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 80 |
AMNESIA |
1 |
0.0000 |
| 81 |
SOMNOLENCE |
3 |
0.0000 |
| 82 |
BURNING SENSATION |
1 |
0.0000 |
| 83 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 84 |
BRONCHITIS |
1 |
0.0000 |
| 85 |
WEIGHT INCREASED |
3 |
0.0000 |
| 86 |
HALLUCINATION |
1 |
0.0000 |
| 87 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 88 |
BACK PAIN |
3 |
0.0000 |
| 89 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 90 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 91 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 92 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 93 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 94 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 95 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 96 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 97 |
SWELLING |
1 |
0.0000 |
| 98 |
CONTUSION |
1 |
0.0000 |
| 99 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 100 |
DYSPEPSIA |
1 |
0.0000 |
| 101 |
HEART RATE INCREASED |
1 |
0.0000 |
| 102 |
FLUSHING |
1 |
0.0000 |
| 103 |
ILLNESS |
1 |
0.0000 |
| 104 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 105 |
CONSTIPATION |
2 |
0.0000 |
| 106 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 107 |
PAIN |
5 |
0.0000 |
| 108 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 109 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 110 |
PRURITUS |
3 |
0.0000 |
| 111 |
DRY SKIN |
1 |
0.0000 |
| 112 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 113 |
VISION BLURRED |
1 |
0.0000 |
| 114 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 115 |
HYPOAESTHESIA |
1 |
0.0000 |
| 116 |
HOSPITALISATION |
1 |
0.0000 |
| 117 |
PARAESTHESIA |
1 |
0.0000 |
| 118 |
FALL |
2 |
0.0000 |
| 119 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 120 |
CHEST PAIN |
1 |
0.0000 |
| 121 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 122 |
ERYTHEMA |
1 |
0.0000 |
| 123 |
ARTHRALGIA |
2 |
0.0000 |
| 124 |
DIZZINESS |
2 |
0.0000 |
| 125 |
DRUG INEFFECTIVE |
5 |
0.0000 |
| 126 |
NAUSEA |
3 |
0.0000 |
| 127 |
COUGH |
1 |
0.0000 |
| 128 |
ANXIETY |
1 |
0.0000 |
| 129 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 130 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 131 |
DIARRHOEA |
2 |
0.0000 |
| 132 |
FATIGUE |
2 |
0.0000 |
| 133 |
RASH |
1 |
0.0000 |
| 134 |
OFF LABEL USE |
2 |
0.0000 |
| 135 |
MALAISE |
1 |
0.0000 |
| 136 |
VOMITING |
1 |
0.0000 |
| 137 |
HEADACHE |
1 |
0.0000 |
| 138 |
DEATH |
1 |
0.0000 |